This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barbut, F Articles by Petit, J C Search for Related Content PubMed PubMed Citation Articles by Barbut, F Articles by Petit, J C

Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea.

Service de Bactériologie Virologie, Hôpital Saint-Antoine, Paris, France.

ABSTRACT

Enzyme immunoassays (EIAs) based on monoclonal antibodies for the detection of Clostridium difficile toxins have recently been developed for clinical use. The aim of this study was to compare three commercially available EIAs, two for toxin A (Premier C. difficile Toxin A; Meridian, Osi, Elancourt, France; and Vidas C. difficile Toxin A; bioMérieux, Marcy l'Etoile, France) and one for toxins A and B (Cytoclone A + B EIA; Cambridge Biotech Corp., Codiapharm, Evian, France), with a cytotoxicity assay and toxigenic culture for the diagnosis of C. difficile-associated diarrhea (CDAD). The study was performed with 285 fresh stools from 285 patients with suspected CDAD. In case of disagreement, the tests were repeated on a frozen aliquot of the same stool sample, and the patient's chart was reviewed. CDAD diagnosis was established in 55 cases (incidence, 19.3%). The sensitivities and specificities of the methods were, respectively, 92.7 and 100% for the cytotoxicity assay, 96.4 and 99.1% for toxigenic culture, 75.5 and 97.8% for Cytoclone, 65.4 and 99.6% for Premier, and 65.4 and 100% for Vidas. The results were uninterpretable in 3.2% of cases with Cytoclone, 0.3% with Premier, and 2.5% with Vidas. We conclude that the cytotoxicity assay and toxigenic culture remain the best methods for the diagnosis of CDAD even though they lack standardization and require 48 to 96 h to obtain the result. Despite their rapidity and simplicity, EIAs are not sensitive enough to be relied on as the sole laboratory test.

This article has been cited by other articles:

• Garey, K. W, Graham, G., Gerard, L., Dao, T., Jiang, Z. D., Price, M., DuPont, H. L (2006). Prevalence of Diarrhea at a University Hospital and Association with Modifiable Risk Factors. The Annals of Pharmacotherapy 40: 1030-1034 [Abstract] [Full Text]  
• Barbut, F., Decre, D., Lalande, V., Burghoffer, B., Noussair, L., Gigandon, A., Espinasse, F., Raskine, L., Robert, J., Mangeol, A., Branger, C., Petit, J.-C. (2005). Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54: 181-185 [Abstract] [Full Text]  
• Delmee, M., Van Broeck, J., Simon, A., Janssens, M., Avesani, V. (2005). Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 54: 187-191 [Abstract] [Full Text]  
• Lemee, L., Dhalluin, A., Testelin, S., Mattrat, M.-A., Maillard, K., Lemeland, J.-F., Pons, J.-L. (2004). Multiplex PCR Targeting tpi (Triose Phosphate Isomerase), tcdA (Toxin A), and tcdB (Toxin B) Genes for Toxigenic Culture of Clostridium difficile. J. Clin. Microbiol. 42: 5710-5714 [Abstract] [Full Text]  
• Poutanen, S. M., Simor, A. E. (2004). Clostridium difficile-associated diarrhea in adults. CMAJ 171: 51-58 [Abstract] [Full Text]  
• Goncalves, C., Decre, D., Barbut, F., Burghoffer, B., Petit, J.-C. (2004). Prevalence and Characterization of a Binary Toxin (Actin-Specific ADP-Ribosyltransferase) from Clostridium difficile. J. Clin. Microbiol. 42: 1933-1939 [Abstract] [Full Text]  
• Johal, S S, Hammond, J, Solomon, K, James, P D, Mahida, Y R (2004). Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy. Gut 53: 673-677 [Abstract] [Full Text]  
• Thomas, C., Stevenson, M., Riley, T. V. (2003). Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 51: 1339-1350 [Abstract] [Full Text]  
• Belanger, S. D., Boissinot, M., Clairoux, N., Picard, Francois. J., Bergeron, M. G. (2003). Rapid Detection of Clostridium difficile in Feces by Real-Time PCR. J. Clin. Microbiol. 41: 730-734 [Abstract] [Full Text]  
• Gravisse, J., Barnaud, G., Hanau-Bercot, B., Raskine, L., Riahi, J., Gaillard, J. L., Sanson-Le-Pors, M. J. (2003). Clostridium difficile Brain Empyema after Prolonged Intestinal Carriage. J. Clin. Microbiol. 41: 509-511 [Abstract] [Full Text]  
• Barbut, F., Lalande, V., Burghoffer, B., Thien, H. V., Grimprel, E., Petit, J.-C. (2002). Prevalence and Genetic Characterization of Toxin A Variant Strains of Clostridium difficile among Adults and Children with Diarrhea in France. J. Clin. Microbiol. 40: 2079-2083 [Abstract] [Full Text]  
• Bartlett, J. G. (2002). Antibiotic-Associated Diarrhea. NEJM 346: 334-339 [Full Text]  
• O'Connor, D., Hynes, P., Cormican, M., Collins, E., Corbett-Feeney, G., Cassidy, M. (2001). Evaluation of Methods for Detection of Toxins in Specimens of Feces Submitted for Diagnosis of Clostridium difficile- Associated Diarrhea. J. Clin. Microbiol. 39: 2846-2849 [Abstract] [Full Text]  
• Lozniewski, A., Rabaud, C., Dotto, E., Weber, M., Mory, F. (2001). Laboratory Diagnosis of Clostridium difficile-Associated Diarrhea and Colitis: Usefulness of Premier Cytoclone A+B Enzyme Immunoassay for Combined Detection of Stool Toxins and Toxigenic C. difficile Strains. J. Clin. Microbiol. 39: 1996-1998 [Abstract] [Full Text]  
• Fedorko, D. P., Engler, H. D., O'Shaughnessy, E. M., Williams, E. C., Reichelderfer, C. J., Smith, W. I. Jr. (1999). Evaluation of Two Rapid Assays for Detection of Clostridium difficile Toxin A in Stool Specimens. J. Clin. Microbiol. 37: 3044-3047 [Abstract] [Full Text]  
• Alfa, M. J., Du, T., Beda, G. (1998). Survey of Incidence of Clostridium difficile Infection in Canadian Hospitals and Diagnostic Approaches. J. Clin. Microbiol. 36: 2076-2080 [Abstract] [Full Text]